Northern Trust
CRVO icon

Northern Trust’s CervoMed CRVO Stock Holding History

Northern Trust’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Sell
13,318
-16,726
-56% -$58.9K ﹤0.01% 4290
2026
Q1 		$118K Sell
30,044
-605
-2% -$3.16K ﹤0.01% 4063
2025
Q4 		$242K Buy
30,649
+8,095
+36% +$65K ﹤0.01% 3915
2025
Q3 		$182K Sell
22,554
-2,800
-11% -$24K ﹤0.01% 4009
2025
Q2 		$159K Sell
25,354
-31,346
-55% -$267K ﹤0.01% 4002
2025
Q1 		$519K Buy
56,700
+5,792
+11% +$22.1K ﹤0.01% 3565
2024
Q4 		$119K Sell
50,908
-2,784
-5% -$27.1K ﹤0.01% 4122
2024
Q3 		$784K Buy
+53,692
New +$832K ﹤0.01% 3437
2022
Q2 		– Sell
-2,679
Closed -$50K – 4757
2022
Q1 		$50K Hold
2,679
– – ﹤0.01% 4532
2021
Q4 		$61K Hold
2,679
– – ﹤0.01% 4555
2021
Q3 		$102K Hold
2,679
– – ﹤0.01% 4389
2021
Q2 		$147K Hold
2,679
– – ﹤0.01% 4253
2021
Q1 		$184K Buy
2,679
+1,240
+86% +$104K ﹤0.01% 4136
2020
Q4 		$86K Sell
1,439
-18
-1% -$1.05K ﹤0.01% 4143
2020
Q3 		$92K Buy
1,457
+18
+1% +$1.37K ﹤0.01% 3983
2020
Q2 		$105K Buy
+1,439
New +$87.5K ﹤0.01% 3904
2018
Q4 		– Sell
-27
Closed -$13K – 4280
2018
Q3 		$13K Hold
27
– – ﹤0.01% 4236
2018
Q2 		$14K Hold
27
– – ﹤0.01% 4235
2018
Q1 		$17K Buy
+27
New +$23.4K ﹤0.01% 4177

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Northern Trust's CRVO Position: Q2 2026 in Review

Northern Trust reduced its CervoMed (CRVO) stake by 56% in Q2 2026, selling an estimated $58.9K and leaving 13,318 shares worth $41.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4290.

Northern Trust first reported a position in CRVO in Q1 2018 and has held it in 19 quarters since. The position peaked at $784K in Q3 2024. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Northern Trust held 13,318 shares of CervoMed worth $41.3K as of Q2 2026.
  • Northern Trust sold 16,726 CervoMed shares in Q2 2026, an estimated $58.9K.
  • CervoMed made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4290 holding.
  • Northern Trust first reported a position in CervoMed in Q1 2018 and has held it in 19 quarters since.
  • Northern Trust's CervoMed position peaked at $784K in Q3 2024.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.